Alkermes (ALKS) Commences Arbitration Related to License Agreements with Janssen Pharmaceutica
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Johnson & Johnson (JNJ) PT Raised to $205 at Credit Suisse
April 20, 2022 6:51 AM EDTCredit Suisse analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $205.00 (from $200.00) while maintaining a Outperform rating.
... MoreJohnson & Johnson (JNJ) PT Raised to $196 at Raymond James
April 20, 2022 5:56 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $196.00 (from $195.00) while maintaining a Outperform rating following results.
The analyst commented, "1Q results were mixed and the downward guidance revision, although not operational, still causes us to... More
Johnson & Johnson (JNJ) PT Raised to $210 at Citi
April 19, 2022 3:11 PM EDTCiti analyst Joanna Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $210.00 (from $203.00) while maintaining a Buy rating following earnings.
... More